GELS · Gelteq Ltd
$0.67
-0.11 (-13.61%)
At close · Jul 27
Market Cap
$7.51M
Shares
10.71M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.74
Open$0.65
Day$0.64–0.88
52W$0.39–2.02
Avg vol 30d6.6M
Short int112K · 1.0% float · 2.7d
Short vol9%
DataOct 2024–Jul 2026
Up next
FQ1-27 quarter ends
~Sep 30, 2026
Est
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Neutral
Momentum
Weak
Sentiment
Bullish
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 18.6 · elevated
Equity put/call 0.79
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−11%
below
Price vs 50-day avg
+18%
above
RSI (14)
57
neutral
MACD trend
Positive
52-week position
22%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+8%
trailing
6-month return
−26%
trailing
YTD return
−7%
this year
Relative strength
−33%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $1 › 200d $1 — 200d above 50d
Institutional flow
Accumulating
+67% holders QoQ · +3 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
1.05% of float · ▼ -32.9% MoM · 2.7 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
5 holders — mid 1-yr range
Squeeze score
37
low risk · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
241%
annualized · 1-yr
Max drawdown
−80%
past year
ATR
15.9%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−11%
Bearish
Price vs 50-day avg
+18%
Bullish
RSI (14)
57
Neutral
MACD trend
Positive
Bullish
52-week position
22%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $1 › 200d $1 — 200d above 50d
Institutional flow
Accumulating
+67% holders QoQ · +3 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
1.05% of float · ▼ -32.9% MoM · 2.7 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
5 holders — mid 1-yr range
Price context
position in its 52-week range
52-wk low $0
Now $1 · 22%
52-wk high $2
vs 200-day avg -11%
vs 50-day avg +18%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Drug Manufacturers - Specialty & Generic — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
GELS
this stock
Gelteq Ltd
|
$7.51M | -7.1% | — | — | 1.0% |
|
TAK
Takeda Pharmaceutical Co Ltd
|
$55.06B | +10.6% | — | — | 0.1% |
|
GALDY
Galderma Group AG/ADR
|
$49.54B | +2.5% | — | — | 0.0% |
|
JHPCY
Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR
|
$45.13B | — | — | — | 0.0% |
|
HLN
Haleon plc
|
$43.07B | -4.0% | — | — | 0.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Reducing
Holders
5
- % held
- 0.6%
- Net QoQ
- -22.9K sh
- Top holder
- WEDBUSH SECURITIES INC
Held
Float
Short & Settlement
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| GELS | +26.2% | +7.7% | -26.4% | +10.9% | -7.1% |
| SPY | -1.7% | +0.7% | +6.4% | -1.2% | +8.3% |
| vs SPY | +27.8% | +7.0% | -32.8% | +12.1% | -15.4% |